Sweden

Dela

Välj datumintervall -
Taggar ( valda)

FluoGuide has completed a directed share issue raising SEK 75 million

Copenhagen, Denmark, 12 May 2021 – FluoGuide A/S (publ a developer of surgical precision solutions within oncology (“FluoGuide” or the “Company”) (Nasdaq First North Growth Market: FLUO) hereby announces that the Company has successfully completed a directed share issue raising SEK 75 million in gross proceeds (the “Directed Share Issue”).The board of directors of FluoGuide has, based on the  authorization to increase the share capital in the Company’s articles of association section 3.2.3 granted by the annual general meeting on 9 February 2021, and as indicated in the Company’s press

BioStock Studio: FluoGuide om listbytet och vägen framåt

Sedan danska FluoGuide börsnoterades 2019 har utvecklingen gått snabbt och man genomför nu en kombinerad fas I/II-studie med sin produkt FG001. Produkten har förmågan att göra cancertumörer självlysande vid operationer vilket inte bara underlättar kirurgernas arbete, utan även förbättrar säkerheten och utfallet av operationerna. Som ett led i bolagets utveckling då man nu går in i en mer internationell fas genomför bolaget ett listbyte från Spotlight Stock Market i Danmark till svenska Nasdaq First North Growth Market. Vd Morten Albrechtsen och Andreas Kjaer, grundare och ordförande för

BioStock Studio: Danska FluoGuide om den pågående kliniska studien

Läkemedelskandidaten FG001, som utvecklas av danska FluoGuide, ger ett mer precist stöd till kirurger för att kunna avlägsna cancer vid operationer än vad som finns tillgängligt på marknaden idag. Just nu genomför bolaget sin kombinerade fas I/II-studie med kandidaten där man i första delen vill fastslå den optimala dosen för att under studiens andra del mäta vilken förbättring FG001 kan innebära för patienterna. Morten Albrechtsen, vd för FluoGuide, kom till BioStocks studio i Lund för att berätta mer.Se hela intervjun med Morten Albrechtsen på biostock.se: https://www.biostock.se/2021/

FluoGuide obtains patent protection for FG001 in Australia

Copenhagen, Denmark, 30 November 2020 – FluoGuide A/S (“FluoGuide” or the “Company”) announces that the Company has successfully secured patent protection for its lead clinical asset FG001 in Australia. The protection is granted by the Australian Commissioner of Patents. The patent number is 2015317444 and will remain valid until September 2035.FG001 is designed to allow surgeons to clearly delignate cancer from normal tissue during surgery through a novel uPAR-targeted luminescent technology and is currently used in a phase I/II clinical trial in guiding surgery of high grade glioma.

SEB initiates commissioned research on FluoGuide

Copenhagen, Denmark, 30 November 2020 – FluoGuide A/S (“FluoGuide” or the “Company”) has entered into an agreement with Skandinaviska Enskilda Banken (“SEB”) on commissioned research coverage.Starting today, SEB will initiate its commissioned research, meaning that SEB will continuously monitor and analyze FluoGuide’s operations, its products, markets, and competitors. The initial research report is available here .

FluoGuide A/S publishes the Annual Report for 2019

FluoGuide A/S (“FluoGuide” or “the Company”) hereby publishes the Annual Report for 2019. The Annual Report has been approved for issue by the Board of Directors and the CEO and will be subject to adoption by the Annual General Meeting on 23 April 2020. The Annual Report for the financial year 2019 is now available on the company's website and at the company's office (Ole Maaløes Vej 3, 2200 København N).The full annual report can be downloaded here: https://fluoguide.com/2020-fluoguide-annual-report-2019/.

106/19 – FluoGuide A/S will be listed on Spotlight Stock Market on May 7, 2019

The trading in FluoGuide AS’s shares and subscription options will take place from May 7, 2019. Short name for the share is FLUO and short name for the subscription option is FLUO TO1. Information about the company’s share capital: Share capital consist of 722,427:40 DKK divided into 7 224 274 shares as per todays date. Information about the share: Short name: FLUOShare name: FluoGuideISIN-code: DK0061123312Orderbook-ID: 55V9CFI: ESVUFNFISN: FluoGuide AS/-Organisation number: 39296438LEI: DK89450078OGAJQ84J9R62Par Value: 0,1 DKKFirst day of trading: May 7, 2019

Det finns inga träffar som matchar nuvarande filter
Det finns inga fler träffar som matchar nuvarande filter
Tillbaka till sidans topp